NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice

References

• Department of Health. A Policy Framework for Commissioning Cancer Services: A Report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4014366.pdf. 1995. London: DH.
   Google Scholar
• Department of Health. The NHS Cancer Plan: A Plan for Investment, A Plan for Reform. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4014513.pdf. 2000. London: DH.
   Google Scholar
• NHS Executive. Health Service Circular HSC 2000/021: Improving the Quality of Cancer Services. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4012180.pdf. 2000. London: NHS Executive.
   Google Scholar
• Taylor C, Munro AJ, Glynne-Jones R, . Multidisciplinary team working in cancer: what is the evidence? BMJ 2010;340:c951.
   PubMed Web of Science ®Google Scholar
• Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP. Years of life lost (YLL) from cancer is an important measure of population burden - and should be considered when allocating research funds. Br J Cancer 2005;9:241–5.
   Google Scholar
• Westphal M, Hilt DC, Bortey E. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-oncol 2003;5:79–88.
   PubMed Web of Science ®Google Scholar
• National Institute of Health and Clinical Excellence. TA121 Glioma (newly diagnosed and high grade) - carmustine implants and temozolomide. http://www.nice.org.uk/nicemedia/live/11620/34049/34049.pdf. 2007. London: NICE.
   Google Scholar
• National Institute of Health and Clinical Excellence. Improving outcomes for people with brain and other CNS tumours. http://www.nice.org.uk/nicemedia/live/10905/28963/28963.pdf. 2006. London: DH.
   Google Scholar
• Stupp R, Mason WP, van den Bent MJ, . Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. New Engl J Med 2005;352:987–96.
   PubMed Web of Science ®Google Scholar
• Bock HC, Puchner MJ, Lohmann F, . First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Neurosurg Rev 2010;33:441–9.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Ellison DW, Mendelow AD. Surgery for malignant gliomas: mechanistic reasoning and slippery statistics. Lancet Neurol 2005;4:413–22.
   PubMed Web of Science ®Google Scholar
• Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K. Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev 2011;3:CD007294.
   Google Scholar
• McGirt MJ, Than KD, Weingart JD, . Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg 2009;110:583–8.
   PubMed Web of Science ®Google Scholar
• Menei P, Metellus P, Parot-Schinkel E, . Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experience. Ann Surg Oncol 2010;17:1740–6.
   PubMed Web of Science ®Google Scholar
• Noel G, Schott R, Froelich S, . Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (Carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas. Int J Radiat Oncol Biol Phys 2011;Feb 5: [Epub ahead of Print].
   Google Scholar
• Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7:392–401.
   PubMed Web of Science ®Google Scholar
• Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34: 45–60.
   PubMed Web of Science ®Google Scholar
• Whittle IR, Lyles S, Walker M. Gliadel therapy given for first resection of malignant glioma: a single centre study of the potential use of Gliadel. Br J Neurosurg 2003;17:352–4.
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours of the Central Nervous System, 4th ed. Lyon: IARC, 2007.
   Google Scholar